15-31483457-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001382637.1(OTUD7A):āc.2639G>Cā(p.Arg880Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000138 in 1,379,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 32)
Exomes š: 0.000014 ( 0 hom. )
Consequence
OTUD7A
NM_001382637.1 missense
NM_001382637.1 missense
Scores
1
2
16
Clinical Significance
Conservation
PhyloP100: 3.87
Genes affected
OTUD7A (HGNC:20718): (OTU deubiquitinase 7A) The protein encoded by this gene is a deubiquitinizing enzyme and possible tumor suppressor. The encoded protein acts on TNF receptor associated factor 6 (TRAF6) to control nuclear factor kappa B expression. However, this gene is downregulated by SNAIL1 in hepatocellular carcinoma cells, contributing to their progression and malignancy. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0804919).
BS2
High AC in GnomAdExome4 at 17 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTUD7A | NM_001382637.1 | c.2639G>C | p.Arg880Pro | missense_variant | 13/13 | ENST00000307050.6 | NP_001369566.1 | |
OTUD7A | NM_130901.3 | c.2618G>C | p.Arg873Pro | missense_variant | 14/14 | NP_570971.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTUD7A | ENST00000307050.6 | c.2639G>C | p.Arg880Pro | missense_variant | 13/13 | 1 | NM_001382637.1 | ENSP00000305926 | P2 | |
OTUD7A | ENST00000560598.2 | c.2618G>C | p.Arg873Pro | missense_variant | 14/14 | 5 | ENSP00000453883 | A2 | ||
OTUD7A | ENST00000678495.1 | c.2618G>C | p.Arg873Pro | missense_variant | 11/11 | ENSP00000503326 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 149310Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
149310
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000320 AC: 15AN: 46914Hom.: 0 AF XY: 0.000391 AC XY: 11AN XY: 28140
GnomAD3 exomes
AF:
AC:
15
AN:
46914
Hom.:
AF XY:
AC XY:
11
AN XY:
28140
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000138 AC: 17AN: 1230424Hom.: 0 Cov.: 29 AF XY: 0.0000182 AC XY: 11AN XY: 606054
GnomAD4 exome
AF:
AC:
17
AN:
1230424
Hom.:
Cov.:
29
AF XY:
AC XY:
11
AN XY:
606054
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000134 AC: 2AN: 149310Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 72774
GnomAD4 genome
AF:
AC:
2
AN:
149310
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
72774
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.2618G>C (p.R873P) alteration is located in exon 11 (coding exon 11) of the OTUD7A gene. This alteration results from a G to C substitution at nucleotide position 2618, causing the arginine (R) at amino acid position 873 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Gain of loop (P = 0.0045);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at